Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CRISTINA BARNES

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1548934219
CMS profile
11221316
Location
TULSA, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,475.56

104 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,391.56 100
Consulting Fee $1,050.00 3
Education $34.00 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CRISTINA BARNES

NPI 1548934219 · CMS profile ID 11221316

Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family

TULSA, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1548934219?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CRISTINA BARNES, NPI 1548934219, CMS profile ID 11221316. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1548934219?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). CRISTINA BARNES, NPI 1548934219, CMS profile ID 11221316. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1548934219?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
CRISTINA BARNES, NPI 1548934219, CMS profile ID 11221316, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1548934219?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

104 matching records · $3,475.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 104 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 104.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
CSL Behring $23.9207/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232341170 CMS
Grifols USA, LLC $12.6906/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249570939 CMS
GENZYME CORPORATION $24.7106/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286976 CMS
AstraZeneca Pharmaceuticals LP $20.5006/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207235972 CMS
GlaxoSmithKline, LLC. $15.7406/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191418456 CMS
GENZYME CORPORATION $30.0006/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286978 CMS
GlaxoSmithKline, LLC. $16.9006/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190504353 CMS
Novartis Pharmaceuticals Corporation $22.5805/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200159658 CMS
Grifols USA, LLC $28.5005/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249570933 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.8405/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224063468 CMS
Galderma Laboratories, L.P. $14.5605/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234727722 CMS
AstraZeneca Pharmaceuticals LP $18.6405/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206575076 CMS
GENZYME CORPORATION $28.2405/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286962 CMS
GENZYME CORPORATION $28.5605/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286964 CMS
PFIZER INC. $14.8204/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230144587 CMS
GENZYME CORPORATION $16.4704/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286958 CMS
AstraZeneca Pharmaceuticals LP $22.7704/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206626286 CMS
GlaxoSmithKline, LLC. $14.5404/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190535816 CMS
AstraZeneca Pharmaceuticals LP $18.0704/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207256126 CMS
GENZYME CORPORATION $25.8104/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286948 CMS
GlaxoSmithKline, LLC. $16.8204/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190437538 CMS
GENZYME CORPORATION $24.6704/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286952 CMS
Blueprint Medicines Corporation $19.4303/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235822399 CMS
AstraZeneca Pharmaceuticals LP $22.5203/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206621928 CMS
GENZYME CORPORATION $30.7603/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286944 CMS
GENZYME CORPORATION $17.4003/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286942 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.7703/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223978583 CMS
AstraZeneca Pharmaceuticals LP $124.9403/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206983088 CMS
AstraZeneca Pharmaceuticals LP $16.1203/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206587923 CMS
GlaxoSmithKline, LLC. $15.7103/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190629148 CMS
GENZYME CORPORATION $28.4803/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286946 CMS
GENZYME CORPORATION $27.2302/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286934 CMS
AstraZeneca Pharmaceuticals LP $19.7802/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206696984 CMS
CSL Behring $9.7902/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232341152 CMS
AstraZeneca Pharmaceuticals LP $15.5202/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206730302 CMS
AstraZeneca Pharmaceuticals LP $21.5502/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206432152 CMS
GENZYME CORPORATION $33.6102/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286936 CMS
Novartis Pharmaceuticals Corporation $57.7502/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200159636 CMS
AstraZeneca Pharmaceuticals LP $17.2402/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206165156 CMS
Lilly USA, LLC $16.2102/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187094141 CMS
AstraZeneca Pharmaceuticals LP $19.1202/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206412937 CMS
Regeneron Healthcare Solutions, Inc. $210.0002/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1213087870 CMS
Regeneron Healthcare Solutions, Inc. $210.0002/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1213087872 CMS
Regeneron Healthcare Solutions, Inc. $630.0002/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1213087874 CMS
GENZYME CORPORATION $18.6802/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286922 CMS
GlaxoSmithKline, LLC. $12.5702/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191789956 CMS
AstraZeneca Pharmaceuticals LP $14.0701/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206831571 CMS
ARS Pharmaceuticals Operations, Inc. $23.6601/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245899136 CMS
GENZYME CORPORATION $24.2701/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233286910 CMS
AstraZeneca Pharmaceuticals LP $14.7001/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206812791 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $713.71 24
PY2022 $2,111.50 112
PY2023 $2,704.02 120
PY2024 $2,083.98 78
PY2025 $3,475.56 104

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Recipient $1,493.55 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient AbbVie Inc. $20.13 06/12/2023 Covered Recipient Non-Physician Practitioner Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE) No dispute reported 06/30/2026 998355391
Recipient AbbVie Inc. $52.75 05/12/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355379
Recipient AbbVie Inc. $64.33 05/12/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355381
Recipient AbbVie Inc. $62.50 05/12/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355383
Recipient AbbVie Inc. $82.02 05/12/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355385
Recipient AbbVie Inc. $556.89 05/12/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355387
Recipient AbbVie Inc. $107.48 05/12/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355389
Recipient AbbVie Inc. $327.55 05/11/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355373
Recipient AbbVie Inc. $100.00 05/11/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355375
Recipient AbbVie Inc. $119.90 05/11/2023 Covered Recipient Non-Physician Practitioner A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 998355377